I think it will be great if they can reactivate human atopic dermatitis trials based on the canine study.
It was really a big set back when they failed to see positive results on the previous phase 2 trial despite promising findings during phase 1.
I think atopic dermatitis, and probably acne as well, require a higher strength CBD, the one they are going to try at the Rosacea trial.
BOT - Anything but charting, page-2769
-
- There are more pages in this discussion • 6,150 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
0.015(4.17%) |
Mkt cap ! $590.6M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 40.0¢ | 36.5¢ | $10.56M | 27.45M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 75348 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 514698 | 3 |
View Market Depth
| Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
| BOT (ASX) Chart |